Nuvectis Pharma (NVCT) Q2 2026 Earnings

5MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.44
-0.38
-0.31
-0.25

Details

Expected EPS
-0.314
Actual EPS
-0.26
Surprise EPS
0.05
Surprise Percent
+17.2%

Description

Nuvectis Pharma (NVCT) has reported earnings of -0.26 per share for Q2 2026.

0 Comments

Share your thoughts